Krishnaswamy Yeleswaram
Chief Development Officer · 5 filings · Latest: Apr 17, 2026
Rapport Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | Apr 17, 2026 | Sale | $39.99 | 20,225 | $808.8K | 246,426 | |
RAPP | KRISHNASWAMY YELESWARAM | — | Apr 17, 2026 | Proposed Sale | $39.54 | 20,225 | $799.7K | — | |
RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | Apr 14, 2026 | Sale | $35.08 | 10,200 | $357.8K | 266,651 | |
RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | Apr 13, 2026 | Sale | $34.97 | 9,165 | $320.5K | 276,851 | |
RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | Apr 10, 2026 | Sale | $34.98 | 500 | $17.5K | 286,016 | |
RAPP | KRISHNASWAMY YELESWARAM | — | Apr 13, 2026 | Proposed Sale | $34.17 | 19,365 | $661.7K | — | |
RAPP | KRISHNASWAMY YELESWARAM | — | Apr 10, 2026 | Proposed Sale | $34.22 | 500 | $17.1K | — | |
RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | Apr 8, 2026 | Sale | $34.90 | 360 | $12.6K | 286,516 | |
RAPP | KRISHNASWAMY YELESWARAM | — | Apr 8, 2026 | Proposed Sale | $33.49 | 360 | $12.1K | — | |
RAPP | Krishnaswamy Yeleswaram | Chief Development Officer | Mar 25, 2026 | Sale | $29.99 | 10,115 | $303.4K | 286,876 | |
RAPP | KRISHNASWAMY YELESWARAM | — | Mar 25, 2026 | Proposed Sale | $28.25 | 10,115 | $285.7K | — | |
RAPP | Krishnaswamy Yeleswaram | — | Jan 2, 2026 | Proposed Sale | $30.05 | 2,840 | $85.3K | — |